These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 9407946

  • 41. Differentiation-associated expression and intracellular localization of cyclin-dependent kinase inhibitor p27KIP1 and c-Jun co-activator JAB1 in neuroblastoma.
    Shen L, Tsuchida R, Miyauchi J, Saeki M, Honna T, Tsunematsu Y, Kato J, Mizutani S.
    Int J Oncol; 2000 Oct; 17(4):749-54. PubMed ID: 10995887
    [Abstract] [Full Text] [Related]

  • 42. Mutational analysis of the human cyclin-dependent kinase inhibitor p27kip1 in primary breast carcinomas.
    Ferrando AA, Balbín M, Pendás AM, Vizoso F, Velasco G, López-Otín C.
    Hum Genet; 1996 Jan; 97(1):91-4. PubMed ID: 8557269
    [Abstract] [Full Text] [Related]

  • 43. Inhibition of adenovirus-mediated p27kip1 gene on growth of esophageal carcinoma cell strain.
    Wu QM, Yu JP, Tong Q, Wang XH, Xie GJ.
    World J Gastroenterol; 2003 Nov; 9(11):2404-8. PubMed ID: 14606065
    [Abstract] [Full Text] [Related]

  • 44. Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients.
    Porter PL, Malone KE, Heagerty PJ, Alexander GM, Gatti LA, Firpo EJ, Daling JR, Roberts JM.
    Nat Med; 1997 Feb; 3(2):222-5. PubMed ID: 9018243
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Potentiation of ceramide-induced apoptosis by p27kip1 overexpression.
    Kim HJ, Ghil KC, Kim MS, Yeo SH, Chun YJ, Kim MY.
    Arch Pharm Res; 2005 Jan; 28(1):87-92. PubMed ID: 15742814
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. p27Kip1 expression inhibits glioblastoma growth, invasion, and tumor-induced neoangiogenesis.
    Schiappacassi M, Lovat F, Canzonieri V, Belletti B, Berton S, Di Stefano D, Vecchione A, Colombatti A, Baldassarre G.
    Mol Cancer Ther; 2008 May; 7(5):1164-75. PubMed ID: 18483304
    [Abstract] [Full Text] [Related]

  • 49. Molecular events of cellular apoptosis and proliferation in the early tendon healing period.
    Unglaub F, Wolf MB, Dragu A, Horch RE.
    J Hand Surg Am; 2010 Apr; 35(4):691-2; author reply 692-3. PubMed ID: 20353869
    [No Abstract] [Full Text] [Related]

  • 50. Adenoviral expression of the cyclin-dependent kinase inhibitor p27Kip1: a strategy for breast cancer gene therapy.
    Rakkar AN, Li Z, Katayose Y, Kim M, Cowan KH, Seth P.
    J Natl Cancer Inst; 1998 Dec 02; 90(23):1836-8. PubMed ID: 9839525
    [No Abstract] [Full Text] [Related]

  • 51. P27Kip1: the "rosebud" of diabetic nephropathy?
    Wolf G, Shankland SJ.
    J Am Soc Nephrol; 2003 Mar 02; 14(3):819-22. PubMed ID: 12595521
    [No Abstract] [Full Text] [Related]

  • 52. Markers of apoptosis.
    Sarkar FH, Li Y.
    Methods Mol Med; 2006 Mar 02; 120():147-60. PubMed ID: 16491600
    [Abstract] [Full Text] [Related]

  • 53. [ATIP, a novel superfamily of microtubule-associated proteins].
    Molina A, Rodrigues-Ferreira S, Di Tommaso A, Nahmias C.
    Med Sci (Paris); 2011 Mar 02; 27(3):244-6. PubMed ID: 21447291
    [No Abstract] [Full Text] [Related]

  • 54. Molecular, Cellular, and Technical Aspects of Breast Cancer Cell Lines as a Foundational Tool in Cancer Research.
    Witt BL, Tollefsbol TO.
    Life (Basel); 2023 Dec 08; 13(12):. PubMed ID: 38137912
    [Abstract] [Full Text] [Related]

  • 55. Characterization, modes of interactions with DNA/BSA biomolecules and anti-tumor activity of newly synthesized dinuclear platinum(II) complexes with pyridazine bridging ligand.
    Zornić S, Simović Marković B, Franich AA, Janjić GV, Jadranin MB, Avdalović J, Rajković S, Živković MD, Arsenijević NN, Radosavljević GD, Pantić J.
    J Biol Inorg Chem; 2024 Feb 08; 29(1):51-73. PubMed ID: 38099936
    [Abstract] [Full Text] [Related]

  • 56. Cytotoxic mechanisms of berberine-phytantriol liquid crystalline nanoparticles against non-small-cell lung cancer.
    Paudel KR, Manandhar B, Singh SK, Gupta G, Hansbro PM, Chellappan DK, Dua K.
    EXCLI J; 2023 Feb 08; 22():516-519. PubMed ID: 37534226
    [No Abstract] [Full Text] [Related]

  • 57. The SW480 cell line, overexpressing PIWIL2 gene, maintains the expression of stemness and proliferation genes in the mice xenografts.
    Kishani Farahani R, Nazemalhosseini Mojarad E, Soleimanpour-Lichaei HR.
    Gastroenterol Hepatol Bed Bench; 2023 Feb 08; 16(1):492-498. PubMed ID: 37070109
    [Abstract] [Full Text] [Related]

  • 58. Enhanced anticancer potency with reduced nephrotoxicity of newly synthesized platin-based complexes compared with cisplatin.
    Salehi R, Abyar S, Ramazani F, Khandar AA, Hosseini-Yazdi SA, White JM, Edalati M, Kahroba H, Talebi M.
    Sci Rep; 2022 May 18; 12(1):8316. PubMed ID: 35585092
    [Abstract] [Full Text] [Related]

  • 59. The Renaissance of Cyclin Dependent Kinase Inhibitors.
    Ettl T, Schulz D, Bauer RJ.
    Cancers (Basel); 2022 Jan 07; 14(2):. PubMed ID: 35053461
    [Abstract] [Full Text] [Related]

  • 60. Chemopreventive effects of pterostilbene through p53 and cell cycle in mouse lung of squamous cell carcinoma model.
    Surien O, Ghazali AR, Masre SF.
    Sci Rep; 2021 Jul 21; 11(1):14862. PubMed ID: 34290382
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.